CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab.
about
Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritisUpdate on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.[CD30-positive anaplastic large cell T-cell lymphoma developing during immunosuppressive therapy of pityriasis rubra pilaris with ustekinumab].Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis.TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response.Biologics in combination with nonbiologics: efficacy and safety.Cutaneous adverse events of biological therapy for psoriasis: review of the literature.The use of ciclosporin in psoriasis.A systematic review of the safety of topical therapies for atopic dermatitis.Biologic therapeutics in the treatment of psoriasis. Part 1: review.Review and clinical perspectives for the use of infliximab in ulcerative colitis.Is there truly a risk of lymphoma from biologic therapies?Golimumab and malignancies: true or false association?Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology.Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.Does p40-targeted therapy represent a significant evolution in the management of plaque psoriasis?Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis.Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis.Biologics in inflammatory disease: infliximab associated risk of lymphoma development.T cell lymphoproliferative disorders associated with anti-tumor necrosis factor alpha antibody therapy for ulcerative colitis: literature summary.Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor alpha therapy.A case for histologic verification of the diagnosis of atypical psoriasis before systemic therapy.
P2860
Q24675306-B61B8B21-F144-4B5B-8474-C5E9F04E9A05Q34078707-14ECF6E6-4C1B-428B-8569-03E8C6744354Q34549176-805C0C19-0485-44EF-BA58-86CEED75C0DCQ35620368-1274590E-9556-426B-B011-0146E8083D3EQ35877202-72D9B991-987D-4496-8186-5F2FA499DB71Q35893172-3D2B6FD4-5EAD-4A4A-AF9D-1C7B7B861457Q36276703-FF2FA09B-2B1E-4E60-9953-0B3380C26883Q36374570-997CCDC2-5D43-4017-B4CF-27E86B8D99ECQ36708358-91AA4A98-24BC-4182-948C-2A05C797565DQ36826201-6E7FB0A0-592B-483B-BA70-7293AF849F0EQ37114650-F9A49B51-CD00-4538-B41D-2C101902AB56Q37400338-FA1C0973-8A44-4A00-B850-E46EF722EA8FQ37725721-B1AE6A90-AED8-45A5-953B-1B93A7796C44Q37798091-7C0B5A5E-C074-46ED-92DF-221E086656E3Q37936458-384746C2-D709-44DF-9A5F-AA085BD7F68BQ37980484-AED4D4BE-170A-4958-9FE1-A527F7C5DFB0Q38023581-2C40BB4B-3B93-4480-80D8-805E6EEA4FBDQ38058361-EF1AA754-E3C6-4152-803D-7385FCD5B045Q38069053-C20684F8-1348-4FE8-9FA4-25853AB1C188Q43004479-45EFD563-5D3C-4499-ACD4-7FE7525E0713Q43072295-0117C1ED-1758-46C4-9BE4-85C3A3767308Q46594660-979DFF95-881D-4E89-826D-63EA1B2284C6Q47561508-329E7163-BAF2-4EBF-A925-F3D0E6C7D5D3Q55452734-CFBB668B-74C5-4896-A8BA-D071BF7BB1DE
P2860
CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
CD30+ T-cell lymphoma in a pat ...... th ciclosporin and infliximab.
@ast
CD30+ T-cell lymphoma in a pat ...... th ciclosporin and infliximab.
@en
type
label
CD30+ T-cell lymphoma in a pat ...... th ciclosporin and infliximab.
@ast
CD30+ T-cell lymphoma in a pat ...... th ciclosporin and infliximab.
@en
prefLabel
CD30+ T-cell lymphoma in a pat ...... th ciclosporin and infliximab.
@ast
CD30+ T-cell lymphoma in a pat ...... th ciclosporin and infliximab.
@en
P2093
P2860
P1476
CD30+ T-cell lymphoma in a pat ...... th ciclosporin and infliximab.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2133.2003.05384.X
P407
P577
2003-07-01T00:00:00Z